Group One Trading
SYRS

Group One Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Group One Trading’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,000
Closed -$2.53K – 8550
2024
Q4 		$2.53K Buy
+11,000
New +$13.2K ﹤0.01% 6663
2024
Q3 		– Sell
-1,000
Closed -$5.16K – 7525
2024
Q2 		$5.16K Sell
1,000
-100
-9% -$525 ﹤0.01% 5938
2024
Q1 		$5.88K Buy
1,100
+600
+120% +$4.15K ﹤0.01% 6117
2023
Q4 		$3.9K Buy
500
+300
+150% +$1.03K ﹤0.01% 6606
2023
Q3 		$790 Hold
200
– – ﹤0.01% 7262
2023
Q2 		$630 Hold
200
– – ﹤0.01% 7341
2023
Q1 		$534 Buy
+200
New +$775 ﹤0.01% 6898
2022
Q4 		– Sell
-100
Closed -$1K – 8256
2022
Q3 		$1K Buy
+100
New +$812 ﹤0.01% 7399
2022
Q1 		– Sell
-800
Closed -$26K – 8876
2021
Q4 		$26K Buy
800
+180
+29% +$7.29K ﹤0.01% 6815
2021
Q3 		$28K Sell
620
-1,150
-65% -$56.1K ﹤0.01% 6975
2021
Q2 		$96K Sell
1,770
-720
-29% -$42.6K ﹤0.01% 6005
2021
Q1 		$186K Buy
2,490
+1,100
+79% +$114K ﹤0.01% 5098
2020
Q4 		$151K Buy
1,390
+1,290
+1,290% +$118K ﹤0.01% 4278
2020
Q3 		$9K Sell
100
-40
-29% -$4.54K ﹤0.01% 5475
2020
Q2 		$15K Buy
140
+100
+250% +$8.98K ﹤0.01% 4964
2020
Q1 		$2K Hold
40
– – ﹤0.01% 5014
2019
Q4 		$3K Buy
+40
New +$2.43K ﹤0.01% 4857
2019
Q3 		– Sell
-50
Closed -$5K – 5645
2019
Q2 		$5K Sell
50
-2,650
-98% -$185K ﹤0.01% 4616
2019
Q1 		$247K Buy
2,700
+1,200
+80% +$83.6K ﹤0.01% 2554
2018
Q4 		$84K Sell
1,500
-50
-3% -$3.8K ﹤0.01% 3284
2018
Q3 		$185K Buy
1,550
+1,400
+933% +$162K ﹤0.01% 3070
2018
Q2 		$15K Sell
150
-460
-75% -$57K ﹤0.01% 4491
2018
Q1 		$79K Buy
610
+350
+135% +$38.3K ﹤0.01% 3397
2017
Q4 		$25K Buy
+260
New +$34.9K ﹤0.01% 4081

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's SYRS Position: Q1 2025 in Review

Group One Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 3,355 shares — an estimated $771 sold.

Group One Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $127K in Q2 2021. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Group One Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 3,355 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $771.
  • Group One Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • Group One Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $127K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.